Literature DB >> 19901211

The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4.

Amitha Domalpally1, Barbara A Blodi, Ingrid U Scott, Michael S Ip, Neal L Oden, Andreas K Lauer, Paul C VanVeldhuisen.   

Abstract

OBJECTIVE: To describe grading procedures for optical coherence tomographic (OCT) images of participants in the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study.
METHODS: Optical coherence tomograms were taken at clinical sites with the Stratus OCT using fast macular and crosshair scan protocols. Paper prints of images were evaluated at a central reading center. Quality evaluation identified the accuracy of OCT-measured retinal thickness data and was categorized as good, fair, borderline, or ungradable. Manual measurement of center point thickness was performed on borderline images. Morphological evaluation identified cystoid spaces, subretinal fluid, and vitreoretinal interface abnormalities. Reproducibility of grading was assessed through formal quality control exercises.
RESULTS: A randomly selected set of 106 images was identified for quality control. The first 2 annual regrades showed 91% and 89% intergrader agreement for OCT quality. Intraclass correlation for manually measured center point thickness was 0.99 per year. For morphological variables, intergrader agreement for cystoid spaces was 83% and 76%. Reproducibility for subretinal fluid and vitreoretinal interface abnormalities could not be interpreted owing to their limited presence in the sample.
CONCLUSION: Optical coherence tomogram evaluation procedures used in the SCORE Study are reproducible and can be used for multicenter longitudinal studies of retinal vein occlusion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901211      PMCID: PMC2788490          DOI: 10.1001/archophthalmol.2009.277

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  19 in total

1.  Characterization of macular edema from various etiologies by optical coherence tomography.

Authors:  Antoine Catier; Ramin Tadayoni; Michel Paques; Ali Erginay; Belkacem Haouchine; Alain Gaudric; Pascale Massin
Journal:  Am J Ophthalmol       Date:  2005-08       Impact factor: 5.258

2.  Evaluation of image artifact produced by optical coherence tomography of retinal pathology.

Authors:  Robin Ray; Sandra S Stinnett; Glenn J Jaffe
Journal:  Am J Ophthalmol       Date:  2005-01       Impact factor: 5.258

3.  Repeatability and reproducibility of fast macular thickness mapping with stratus optical coherence tomography.

Authors:  Antonio Polito; Michele Del Borrello; Miriam Isola; Nicola Zemella; Francesco Bandello
Journal:  Arch Ophthalmol       Date:  2005-10

4.  Imaging of macular diseases with optical coherence tomography.

Authors:  C A Puliafito; M R Hee; C P Lin; E Reichel; J S Schuman; J S Duker; J A Izatt; E A Swanson; J G Fujimoto
Journal:  Ophthalmology       Date:  1995-02       Impact factor: 12.079

5.  Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.

Authors:  Tom H Williamson; Annie O'Donnell
Journal:  Am J Ophthalmol       Date:  2005-05       Impact factor: 5.258

6.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

7.  Errors in retinal thickness measurements obtained by optical coherence tomography.

Authors:  Srinivas R Sadda; Ziqiang Wu; Alexander C Walsh; Len Richine; Jessica Dougall; Richard Cortez; Laurie D LaBree
Journal:  Ophthalmology       Date:  2006-01-10       Impact factor: 12.079

8.  Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.

Authors:  Rogério A Costa; Rodrigo Jorge; Daniela Calucci; Luiz A Melo; José A Cardillo; Ingrid U Scott
Journal:  Retina       Date:  2007-02       Impact factor: 4.256

9.  Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.

Authors:  Simon D M Chen; Venki Sundaram; Jonathan Lochhead; C K Patel
Journal:  Am J Ophthalmol       Date:  2006-03-09       Impact factor: 5.258

10.  Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.

Authors:  E Chew; S Strauber; R Beck; L P Aiello; A Antoszyk; N Bressler; D Browning; R Danis; J Fan; C Flaxel; S Friedman; A Glassman; C Kollman; H Lazarus
Journal:  Ophthalmology       Date:  2007-06       Impact factor: 12.079

View more
  10 in total

1.  Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

Authors:  Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Michael S Ip; Barbara A Blodi; Mary Elizabeth Hartnett; Geoff Cohen
Journal:  Ophthalmology       Date:  2011-02       Impact factor: 12.079

2.  Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.

Authors:  Peggy Auinger; Mary Durbin; Steven Feldon; Mona Garvin; Randy Kardon; John Keltner; Mark Kupersmith; Patrick Sibony; Kim Plumb; Jui-Kai Wang; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-04       Impact factor: 4.799

3.  Optical coherence tomography evaluation in the Multicenter Uveitis Steroid Treatment (MUST) trial.

Authors:  Amitha Domalpally; Michael M Altaweel; John H Kempen; Dawn Myers; Janet L Davis; C Stephen Foster; Paul Latkany; Sunil K Srivastava; Richard J Stawell; Janet T Holbrook
Journal:  Ocul Immunol Inflamm       Date:  2012-11-19       Impact factor: 3.070

4.  Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials.

Authors:  Francis Char DeCroos; Cynthia A Toth; Sandra S Stinnett; Cynthia S Heydary; Russell Burns; Glenn J Jaffe
Journal:  Ophthalmology       Date:  2012-08-28       Impact factor: 12.079

5.  Stratus OCT Quality Control in Two Multi-Centre Multiple Sclerosis Clinical Trials.

Authors:  John L Keltner; Kimberly E Cello; Laura J Balcer; Peter A Calabresi; Clyde E Markowitz; John S Werner
Journal:  Neuroophthalmology       Date:  2011-03-20

6.  Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9.

Authors:  Barbara A Blodi; Amitha Domalpally; Ingrid U Scott; Michael S Ip; Neal L Oden; Julee Elledge; Kelly Warren; Michael M Altaweel; Judy E Kim; Paul C Van Veldhuisen
Journal:  Arch Ophthalmol       Date:  2010-09

7.  Reading Center Characterization of Central Retinal Vein Occlusion Using Optical Coherence Tomography During the COPERNICUS Trial.

Authors:  Francis Char Decroos; Sandra S Stinnett; Cynthia S Heydary; Russell E Burns; Glenn J Jaffe
Journal:  Transl Vis Sci Technol       Date:  2013-12-23       Impact factor: 3.283

Review 8.  Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.

Authors:  Dina Gewaily; Karthikeyan Muthuswamy; Paul B Greenberg
Journal:  Cochrane Database Syst Rev       Date:  2015-09-09

9.  Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion.

Authors:  Tianwei Qian; Mengya Zhao; Yongjing Wan; MengXiao Li; Xun Xu
Journal:  BMJ Open       Date:  2018-12-28       Impact factor: 2.692

10.  Clinical observation of Dan-Hong Hua-Yu oral solution in treating retinal vein occlusion.

Authors:  Tie-Jun Li; Yu-Chen Sun; Qiu-Yan Ma; Yan Wu; Chao Yang; Nan Zhang; Yue Yang; Ying-Xin Yang
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.